Allumiqs is now a Certified biocrates Laboratory Partner

Resource Details

Allumiqs Announces Derek Gooderham’s Appointment to Board of Directors

Halifax, Nova Scotia, September 16, 2024 – Allumiqs, a tech-enabled multiomics contract research organization (CRO), today announced the appointment of Derek Gooderham to its Board of Directors.

Derek, who has been serving as the Chief Commercial Officer since joining Allumiqs in 2023, will now bring his expertise to the Board. As CCO, Derek has been instrumental in driving the Company’s growth through customer-centric solutions sales, marketing, analytics, and portfolio strategy.

“Derek’s extensive experience and strategic commercial vision make him an invaluable addition to our Board,” said Peter Hickey, Chairman of Allumiqs.“He has already made a significant impact as Chief Commercial Officer and we are confident that his insights at the Board level will help us navigate the next phase of our growth.”

With over 30 years of experience in business development leadership across North America, Latin America, and the Caribbean, Derek is known for his exceptional ability to uncover and seize key expansion and advancement opportunities. His extensive background with industry technology leaders IBM and Microsoft underscores his skill in fostering innovative customer and partner relationships, progressing commercial objectives, and enhancing industry presence.

Derek’s appointment to the Board reflects Allumiqs’ commitment to leveraging his deep expertise and strategic approach to further the Company’s continued success.

“I am delighted to continue contributing to Allumiqs’ growth in my CCO role and now as a Director,” said Derek Gooderham. “Our focus on delivering customer-centric, tech-driven solutions positions us well for the biopharma and biotech market opportunities before us. I look forward to collaborating with the Board and our extended team to seize new opportunities and achieve our goals.”

About Allumiqs

Allumiqs is a CRO solutions partner for biotech and biopharma, bringing together LC-MS and multiomics expertise, along with data analytics and insights, to save you time and money in your development pipeline. Our team is your dedicated innovation collaborator, working with you to advance your discoveries with on-demand or customized solutions. allumiqs.com

Media Contact: 

Allumiqs – Andrea Young, ayoung@allumiqs.com